LMG Wealth Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,232
Closed -$33K 108
2023
Q3
$33K Sell
23,232
-744
-3% -$1.05K 0.01% 104
2023
Q2
$27.6K Sell
23,976
-448
-2% -$529 0.01% 105
2023
Q1
$25.9K Sell
24,424
-1,589
-6% -$2.29K 0.01% 104
2022
Q4
$54.4K Buy
+26,013
New +$44.7K 0.02% 107

Other funds holding PGEN

LMG Wealth Partners's PGEN Position: Q4 2023 in Review

LMG Wealth Partners sold out of Precigen (PGEN) in Q4 2023, closing a stake of 23,232 shares — an estimated $33K sold.

LMG Wealth Partners first reported a position in PGEN in Q4 2022 and held it in 4 quarters. The position peaked at $54.4K in Q4 2022. 137 funds tracked by Wall St. Rank hold PGEN as of Q4 2023.

  • LMG Wealth Partners reported no remaining Precigen position as of Q4 2023 after selling out during the quarter.
  • LMG Wealth Partners sold 23,232 Precigen shares in Q4 2023, an estimated $33K.
  • LMG Wealth Partners first reported a position in Precigen in Q4 2022 and held it in 4 quarters.
  • LMG Wealth Partners's Precigen position peaked at $54.4K in Q4 2022.
  • 137 funds tracked by Wall St. Rank held Precigen as of Q4 2023.

Based on LMG Wealth Partners's 13F filing for Q4 2023, filed 23 Jan 2024.